BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1337850)

  • 1. Megakaryocytic leukemia and platelet factor 4.
    Ryo R; Yasunaga M; Saigo K; Yamaguchi N
    Leuk Lymphoma; 1992 Nov; 8(4-5):327-36. PubMed ID: 1337850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of platelet-specific protein mRNAs in different megakaryoblasts using the reverse transcriptase polymerase chain reaction.
    Yasunaga M; Ryo R; Sugano W; Yamaguchi N
    Leuk Lymphoma; 1992 Aug; 7(5-6):505-10. PubMed ID: 1493450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK11-5).
    Adachi M; Ryo R; Sato T; Yamaguchi N
    Exp Hematol; 1991 Oct; 19(9):923-7. PubMed ID: 1893970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and distribution of megakaryoblasts in FAB subtypes of ANLL: an immunocytochemical ultrastructural study.
    Tomasi P; Tallarico A; Vasi V; Scapoli G; Castoldi G
    Haematologica; 1993; 78(2):95-100. PubMed ID: 7688710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
    Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
    Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
    Ryo R; Yoshida A; Yamaguchi N
    Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
    Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
    Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the thrombospondin receptor (CD36) on the cell surface in megakaryoblastic and promegakaryocytic leukemias: increment of the receptor by megakaryocyte differentiation in vitro.
    Imamura N; Ota H; Abe K; Kuramoto A
    Am J Hematol; 1994 Feb; 45(2):181-4. PubMed ID: 7511332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmortem diagnosis of acute megakaryocytic leukemia. Usefulness of immunohistochemistry and tissue hemogram.
    Umezawa A; Yamada T; Ogawa Y; Kuramochi S; Watanabe Y
    Acta Pathol Jpn; 1990 Sep; 40(9):693-8. PubMed ID: 2260477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxidase expression in acute unclassified leukemias: ultrastructural studies in combination with immunophenotyping.
    Heil G; Gunsilius E; Hoelzer D; Thiel E; Heimpel H
    Leuk Lymphoma; 1994 Jun; 14(1-2):103-9. PubMed ID: 7920215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
    Zipursky A; Christensen H; De Harven E
    Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute megakaryoblastic leukemia.
    Gassmann W; Löffler H
    Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analytical study on leukemic megakaryocytic cells using simultaneous demonstration of membrane antigen with monoclonal antibodies and peroxidase cytochemistry at ultrastructural level].
    Enomoto Y; Watanabe Y
    Rinsho Ketsueki; 1988 Aug; 29(8):1150-62. PubMed ID: 2849691
    [No Abstract]   [Full Text] [Related]  

  • 18. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
    Lee WY; Weinberg OK; Pinkus GS
    Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
    Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
    Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of GATA-1 mRNA in human myeloid leukemic cells.
    Guerrasio A; Saglio G; Rosso C; Alfarano A; Camaschella C; Lo Coco F; Biondi A; Rambaldi A; Nicolis S; Ottolenghi S
    Leukemia; 1994 Jun; 8(6):1034-8. PubMed ID: 8207977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.